Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Tiziana Life Sciences	Harrow Health	OptiNose	Medicenna Therapeutics	Calithera Biosciences
Symbol	NASDAQ:TLSA	NASDAQ:HROW	NASDAQ:OPTN	NASDAQ:MDNA	NASDAQ:CALA
Price Information
Current Price	$2.67	$7.05	$3.52	$4.06	$2.35
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.2	1.4	1.6	0.7	1.7
Analysis Score	3.5	3.5	3.3	3.5	3.4
Community Score	2.3	2.1	2.4	0.0	2.8
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.8	1.7	0.0	1.7
Earnings & Valuation Score	0.0	0.6	0.6	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$9.50	$14.00	$18.00	$10.00	$5.20
% Upside from Price Target	255.81% upside	98.58% upside	411.36% upside	146.31% upside	121.28% upside
Trade Information
Market Cap	$171.47 million	$183.18 million	$186.37 million	$215.00 million	$172.30 million
Beta	1.41	1.08	1.03	1.39	1.77
Average Volume	991,225	226,594	452,776	217,671	1,655,910
Sales & Book Value
Annual Revenue	N/A	$51.17 million	$34.63 million	N/A	$22.25 million
Price / Sales	N/A	3.58	5.38	N/A	7.74
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	($0.09) per share	$1.09 per share	$1.48 per share	$0.77 per share	$2.24 per share
Price / Book	N/A	6.47	2.38	N/A	1.05
Profitability
Net Income	$-9,320,000.00	$170,000.00	$-110,050,000.00	$-6,220,000.00	$-89,860,000.00
EPS	($0.03)	($0.29)	($2.63)	($0.19)	($1.90)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	25.18	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-3.94%	-230.14%	N/A	N/A
Return on Equity (ROE)	N/A	-3.52%	-294.64%	-40.19%	-66.64%
Return on Assets (ROA)	N/A	-1.36%	-59.29%	-37.66%	-56.60%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.53%	3.79%	N/A	N/A
Current Ratio	1.86%	2.97%	3.98%	26.75%	7.07%
Quick Ratio	N/A	2.68%	3.76%	26.75%	7.07%
Ownership Information
Institutional Ownership Percentage	N/A	44.37%	62.93%	3.90%	73.99%
Insider Ownership Percentage	N/A	12.43%	38.00%	N/A	11.90%
Miscellaneous
Employees	8	133	204	7	90
Shares Outstanding	64.22 million	25.98 million	52.95 million	52.96 million	73.32 million
Next Earnings Date	6/16/2021 (Estimated)	5/10/2021 (Estimated)	5/6/2021 (Estimated)	5/21/2021 (Estimated)	5/6/2021 (Estimated)
Optionable	Not Optionable	Optionable	Not Optionable	Not Optionable	Optionable

Source	Headline
	Could The Calithera Biosciences, Inc. (NASDAQ:CALA) Ownership Structure Tell Us Something Useful? nasdaq.com - April 9 at 11:05 PM
	Analysts Anticipate Calithera Biosciences, Inc. (NASDAQ:CALA) Will Announce Earnings of -$0.27 Per Share americanbankingnews.com - April 7 at 2:14 AM
	Calithera Biosciences, Inc. (NASDAQ:CALA) Sees Significant Decline in Short Interest americanbankingnews.com - March 31 at 8:28 AM
	We're Keeping An Eye On Calithera Biosciences' (NASDAQ:CALA) Cash Burn Rate finance.yahoo.com - March 29 at 8:59 AM
	Calithera Biosciences Inc (CALA) Q4 2020 Earnings Call Transcript finance.yahoo.com - March 25 at 1:55 AM
	Jefferies Financial Group Comments on Calithera Biosciences, Inc.'s FY2021 Earnings (NASDAQ:CALA) americanbankingnews.com - March 22 at 1:58 AM
	Zacks: Analysts Expect Calithera Biosciences, Inc. (NASDAQ:CALA) Will Announce Earnings of -$0.27 Per Share americanbankingnews.com - March 20 at 6:12 PM
	Q1 2021 Earnings Estimate for Calithera Biosciences, Inc. (NASDAQ:CALA) Issued By SVB Leerink americanbankingnews.com - March 19 at 8:33 AM
	Calithera Biosciences (NASDAQ:CALA) Stock Price Down 5.5% americanbankingnews.com - March 18 at 7:25 PM
	Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q4 2020 Results - Earnings Call Transcript seekingalpha.com - March 18 at 5:07 AM
	Calithera Biosciences (NASDAQ:CALA) Posts Quarterly Earnings Results, Hits Expectations americanbankingnews.com - March 17 at 8:10 AM
	Calithera: Q4 Earnings Snapshot sfgate.com - March 16 at 8:31 PM
	Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights finance.yahoo.com - March 16 at 8:31 PM
	UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, apnews.com - March 12 at 3:50 PM
	UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021 finance.yahoo.com - March 12 at 3:50 PM
	Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 finance.yahoo.com - March 10 at 7:29 AM
	Calithera to Present at the H.C. Wainwright Virtual Global Life Sciences 2021 Conference finance.yahoo.com - March 2 at 7:15 AM
	Calithera to Participate in the 10th Annual SVB Leerink Global Healthcare Conference finance.yahoo.com - February 22 at 9:15 AM
	Calithera Biosciences, Inc. (NASDAQ:CALA) is an exciting stock to watch stocksregister.com - February 7 at 7:28 AM
	Implied Volatility Surging for Calithera Biosciences (CALA) Stock Options finance.yahoo.com - January 13 at 2:49 PM
	INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal ... apnews.com - January 12 at 5:44 AM
	Calithera (CALA) Plunges as CANTANA Study on Telaglenastat Fails finance.yahoo.com - January 5 at 1:29 PM
	Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not ... apnews.com - January 5 at 8:29 AM
	Calithera to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference finance.yahoo.com - January 5 at 8:29 AM
	Why Is It Moving? Analyzing The Downward Movement in Calithera Biosciences's Stock Today msn.com - January 4 at 2:23 PM

Date	Company	Brokerage	Action
12/22/2020	Tiziana Life Sciences	B. Riley	Initiated Coverage
9/21/2020	Tiziana Life Sciences	HC Wainwright	Reiterated Rating
9/10/2019	Tiziana Life Sciences	Laidlaw	Set Price Target
8/16/2019	Harrow Health	Lake Street Capital	Set Price Target
7/16/2020	OptiNose	Piper Sandler	Reiterated Rating
7/16/2020	OptiNose	Royal Bank of Canada	Reiterated Rating
3/5/2020	OptiNose	Cantor Fitzgerald	Lower Price Target
12/18/2019	OptiNose	Cowen	Initiated Coverage
8/13/2019	OptiNose	BMO Capital Markets	Lower Price Target
4/23/2019	OptiNose	Piper Jaffray Companies	Set Price Target
12/17/2020	Medicenna Therapeutics	Oppenheimer	Initiated Coverage
8/24/2020	Medicenna Therapeutics	Brookline Capital Management	Reiterated Rating
8/24/2020	Medicenna Therapeutics	Bloom Burton	Reiterated Rating
1/5/2021	Calithera Biosciences	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Lower Price Target
1/5/2021	Calithera Biosciences	Smith Barney Citigroup	Lower Price Target
1/5/2021	Calithera Biosciences	SVB Leerink	Downgrade
6/2/2020	Calithera Biosciences	William Blair	Reiterated Rating
3/27/2020	Calithera Biosciences	Jefferies Financial Group	Initiated Coverage

(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources